Frequently Asked Questions
The market is segmented based on , By Source (Synthetic, Natural), Type (Empathogens, Dissociatives, Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends & Forecast to 2031.
.
The North America Psychedelic Drugs Market size was valued at USD 2106.77 USD Million in 2021.
The North America Psychedelic Drugs Market is projected to grow at a CAGR of 13.4% during the forecast period of 2022 to 2029.
The market report covers data from the U.S., Canada, Mexico.
